HIV-1 entry inhibitors: new targets, novel therapies

Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants.

Nature immunology·2026

Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Full-length premembrane protein is not required for mature Zika virus particle assembly.

Science translational medicine·2026

Overcoming immunogenic gaps in malaria subunit vaccines by broadening CSP regions targeted.

The Journal of experimental medicine·2026

Luciferase unleashed: Lighting the path to vaccine approval using a novel high-throughput chikungunya virus neutralization assay.

PLoS neglected tropical diseases·2026

Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.

Molecular pharmaceutics·2026

Regulation of IL-10 Expression in B Cells: Are There IL-10-Specific Mechanisms Distinct from General B-Cell Activation signals?

Immunology letters·2026

Aire deficiency disrupts thymic architecture but preserves TCRVβ repertoire diversity while altering thymic output.

Immunology letters·2026

Innate Lymphoid Cells and diet: the multitask cells in metabolic syndrome progression.

Immunology letters·2026

Beyond the M-spike - immunoparesis and multiple myeloma. A narrative review.

Immunology letters·2026

Killing to cure: harnessing poxvirus-driven cell death for viral immunotherapy.

Immunology letters·2026

S-equol shifts afatinib-altered mucosal immune-epithelial defense indices toward baseline and attenuates increases in DEFA5 and SOX9 promoter methylation indices.

Immunology letters·2026

Treatment with CFTR modulators and subsequent remission of AA amyloidosis.

Clinical kidney journal·2026

Correction: Targeting oxidized phosphatidylcholines in SOD1-associated ALS: therapeutic potential of PC-OxPL-VecTab®.

Frontiers in neuroscience·2026

Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels.

Journal of clinical and translational hepatology·2026

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Movement disorders : official journal of the Movement Disorder Society·2026

Implementation of soluble CD38 in blood crossmatching for patients on anti-CD38 therapy: A single-center experience.

Transfusion·2026

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma.

Experimental & molecular medicine·2026

Related Experiment Videos

HIV-1 entry inhibitors: new targets, novel therapies

Related Concept Videos

Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants.

Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields.

Full-length premembrane protein is not required for mature Zika virus particle assembly.

Overcoming immunogenic gaps in malaria subunit vaccines by broadening CSP regions targeted.

Luciferase unleashed: Lighting the path to vaccine approval using a novel high-throughput chikungunya virus neutralization assay.

Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.

Regulation of IL-10 Expression in B Cells: Are There IL-10-Specific Mechanisms Distinct from General B-Cell Activation signals?

Aire deficiency disrupts thymic architecture but preserves TCRVβ repertoire diversity while altering thymic output.

Innate Lymphoid Cells and diet: the multitask cells in metabolic syndrome progression.

Beyond the M-spike - immunoparesis and multiple myeloma. A narrative review.

Killing to cure: harnessing poxvirus-driven cell death for viral immunotherapy.

S-equol shifts afatinib-altered mucosal immune-epithelial defense indices toward baseline and attenuates increases in DEFA5 and SOX9 promoter methylation indices.

Treatment with CFTR modulators and subsequent remission of AA amyloidosis.

Correction: Targeting oxidized phosphatidylcholines in SOD1-associated ALS: therapeutic potential of PC-OxPL-VecTab®.

Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels.

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Implementation of soluble CD38 in blood crossmatching for patients on anti-CD38 therapy: A single-center experience.

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma.

Related Experiment Videos

HIV-1 entry inhibitors: new targets, novel therapies

Related Concept Videos

Related Articles